Navamedic: Annual report 2021 Publisert: 29.04.2022 Navamedic ASA: Q4 2021 financial results Publisert: 17.02.2022 Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022 Navamedic ASA: Invitation to 2021 Fourth quarter presentation Publisert: 14.02.2022 Navamedic ASA: Trading Update Publisert: 23.12.2021 Navamedic ASA has entered into a market making agreement with Norne Securities AS Publisert: 11.11.2021 FørsteForrige89101112NesteSiste
Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022
Navamedic ASA has entered into a market making agreement with Norne Securities AS Publisert: 11.11.2021
